Author

C. Amador

Institute of Genetics and Cancer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A.S.F. Kwong· 1 shared Andrew Mark McIntoshiD· 1 shared Chris HaleyiD· 1 shared H. Vahle· 1 shared K. J. Wittorf· 1 shared M. Caplan· 1 shared M.J. Adams· 1 shared Melisa Chuong· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

A.S.F. Kwong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Methodological Considerations When Using Polygenic Scores to Explore Parent-Offspring Genetic Nurturing Effects

Melisa Chuong, M.J. Adams, A.S.F. Kwong, Chris Haley, C. Amador, Andrew Mark McIntosh

This study examines genetic nurturing effects using polygenic scores in parent-offspring trios and identifies biases when parental phenotypes are included.

Wellcome Open Research · Jan 6, 2026Peer-reviewedGenomics

Loss of FBXO9 enhances proteasome activity and promotes aggressiveness in acute myeloid leukemia

R. W. Hynes-Smith, S. A. Swenson, H. Vahle, K. J. Wittorf, M. Caplan, C. Amador, R. K. Hyde, S. M. Buckley

This study shows loss of FBXO9 increases proteasome activity and promotes aggressiveness in AML, suggesting potential for bortezomib treatment response prediction.

bioRxiv · Aug 12, 2019Cancer Biology